|Day Low/High||68.63 / 69.68|
|52 Wk Low/High||50.71 / 75.72|
For starters, trouble for banks, drugs, energy and M&A.
DuPont (DD) stock received a 'buy' rating at Nomura this morning.
Two of the most-watched mergers undergoing antitrust scrutiny are close to clearance.
In highlights from this week's trading diary and posts, Kass tells us about how the outlook for the market is worsening and shares some pointers on low-priced stocks.
Beijing's apparent desire to see the companies merge adds uncertainty to ChemChina's $43 billion bid for the Swiss fertilizer maker.
In highlights from this week's trading diary and posts, Kass tells us about how his near-term strategy and why Twitter will continue to fly solo.
Dow Chemical rose more than 10% Monday after EU officials resumed their investigation into the company's proposed $130 million merger with DuPont.
Tesla shares rise after the company reports a record number of quarterly deliveries.
Citi raised its rating on shares of both DuPont (DD) and Dow Chemical (DOW) to 'buy' on Monday due to the cost-cutting potential of their $130 billion proposed deal.
Experts say mutual funds' stakes across an industry can thwart competition and that anti-trust regulators should require them to pare their holdings in that case.
Three of the 10 voting members of the Fed's monetary policy committee wanted to raise the target range for short-term interest rates by a quarter of a point.
Doug Kass shares his thoughts on Wells Fargo and Warren Buffett.
Chemours is up over 153% year-to-date and more than 50% since a short-seller targeted the chemical maker.
Despite intense opposition from farm groups and skepticism from government enforcers, the merging crop technology giants say they expect to win approval by end of 2017.
The agreement values the world's biggest seed maker at $128 per share and comes with a promise of $1.5 billion of annual synergies.
Monsanto shares should rise if the $129-per-share deal, including a massive break fee, is confirmed, while Bayer investors appear unsure whether to celebrate or mourn.
Doug Kass shares his thoughts on the continued breakdown in retail stocks and the drop in bond prices.
Jim Cramer is skeptical the Dow Chemical merger with DuPont will be approved by regulators.
Dow Chemical and Dupont's proposed merger could face regulatory hurdles in Europe as regulators paused their review of the deal due to insufficient information provided by the companies.
Bayer increases its latest offer to buy Monsanto, as regulators look closely at agribusiness mergers.
Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.
Monsanto previously rejected a bid of $125 per share, which Bayer said it could increase to up to $127.50 per share.
The proposed merger between Dow Chemical and DuPont could be in jeopardy.
Even if the Dow merger with DuPont fails, Dow is in good shape.
Jim Cramer says he doesn't think the Monsanto and Bayer merger will be approved by regulators.